Menu
ETF
Annual · values2025202420232022
Operating Cash Flow-5.85 M USD-4.86 M USD-7.00 M USD-1.35 M USD
Depreciation & Amortization1012 USD9936 USD24889 USD3863 USD
Stock-Based Compensation1.17 M USD248682 USD624463 USD234088 USD
Capital Expenditures3519 USD43102 USD
Cash Flow from Investing65000 USD-3519 USD-43102 USD
Cash Flow from Financing7.27 M USD4.13 M USD7.06 M USD2.05 M USD
Dividends Paid
Stock Buybacks
Free Cash Flow-7.00 M USD-1.39 M USD

Mangaceuticals Inc. operates as a biotechnology company specializing in the development of plant-based pharmaceuticals. Its primary function is to harness the medicinal properties of exotic fruits and plants, particularly those with potential health benefits, to create pharmaceutical and nutraceutical products. Mangaceuticals Inc. focuses on research and innovation, employing cutting-edge biotechnological techniques to explore the therapeutic potential of natural compounds. The company's offerings have implications across multiple sectors, notably healthcare, wellness, and pharmaceuticals, as it seeks to provide natural alternatives to conventional medicines. The market significance of Mangaceuticals Inc. lies in its commitment to sustainability and the growing consumer demand for natural and holistic healthcare solutions. By integrating the principles of biotechnology and phytotherapy, the company positions itself at the forefront of a niche market segment that values environmental responsibility and health-conscious products. Mangaceuticals Inc. continues to expand its research and development capabilities, aiming to contribute to the evolving landscape of plant-based medicine and meet the needs of a health-aware global population.